Submacular cysticercosis.
Kumar V, Surve A, Kumar P, Sharma A, Azad S.
Eur J Ophthalmol. 2020 Sep;30(5):NP58-NP61. doi: 10.1177/1120672119841542. Epub 2019 Apr 7.
Intravitreal cysticercosis.
Seo MS, Woo JM, Park YG.
Korean J Ophthalmol. 1996 Jun;10(1):55-9. doi: 10.3341/kjo.1996.10.1.55.
Toxoplasmosis in the outer retina.
Miokovic AP, Ratkovic M, Gadzo AP.
Rom J Ophthalmol. 2024 Apr-Jun;68(2):198-201. doi: 10.22336/rjo.2024.37.
Asymptomatic Intraocular Mass.
Andreoli MT, Farooq AV, Mieler WF.
JAMA Ophthalmol. 2016 Jan;134(1):105-6. doi: 10.1001/jamaophthalmol.2015.2522.
[Ocular toxoplasmosis].
Pleyer U, Torun N, Liesenfeld O.
Ophthalmologe. 2007 Jul;104(7):603-15, quiz 616. doi: 10.1007/s00347-007-1535-8.
Diagnostic vitrectomy.
Engel HM, Green WR, Michels RG, Rice TA, Erozan YS.
Retina. 1981;1(2):121-49. doi: 10.1097/00006982-198101020-00009.
Implications of TORCH Diseases in Retinal Development-Special Focus on Congenital Toxoplasmosis.
de Campos VS, Calaza KC, Adesse D.
Front Cell Infect Microbiol. 2020 Oct 26;10:585727. doi: 10.3389/fcimb.2020.585727. eCollection 2020.
Clinical Pearls.
Alexander L.
Optom Vis Sci. 2016 May;93(5):543-4. doi: 10.1097/OPX.0000000000000830.
Animal Models for Toxoplasma gondii Infection.
S Subauste C, Hubal A.
Curr Protoc. 2023 Sep;3(9):e871. doi: 10.1002/cpz1.871.
Epidemiology, pathophysiology, and the future of ocular toxoplasmosis.
Kijlstra A, Petersen E.
Ocul Immunol Inflamm. 2014 Apr;22(2):138-47. doi: 10.3109/09273948.2013.823214. Epub 2013 Oct 16.
